Loading...

Advertisement

Ligand Pharma CEO John Higgins Retires; Todd Davis To Succeed Higgins As CEO

RTTNews | 826 days ago

Ligand Pharma CEO John Higgins Retires; Todd Davis To Succeed Higgins As CEO

(RTTNews) - Ligand Pharmaceuticals Inc. (LGND) announced Monday that John Higgins has retired as Chief Executive Officer, effective as of today. Higgins will resign as a director of the company on December 31, 2022.

The company's board of directors has named Todd Davis as Chief Executive Officer. Davis is currently a member of Ligand's board of directors and is Managing Partner of RoyaltyRx Capital, a special opportunities investment firm he founded in 2018.

Davis has nearly 30 years of experience in biopharmaceutical and life sciences operations and investing.

Prior to founding RoyaltyRx Capital, Davis was a founder and Managing Partner at HealthCare Royalty Partners, a global healthcare investment firm. Previously, he was a partner responsible for biopharmaceutical growth equity investments at Apax Partners.

Davis began his career at Abbott Laboratories, where he held multiple sales and marketing positions of increasing responsibility. Subsequently, he led corporate development and held strategic planning and general management responsibilities at Elan Pharmaceuticals.

Tags: LGND

read more

Ligand Says Merck Receives FDA Approval For CAPVAXIVE For Adults

Ligand Says Merck Receives FDA Approval For CAPVAXIVE For Adults

Ligand Pharmaceuticals Inc. (LGND) announced Tuesday that its collaborator Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, has received approval from the U.S. Food and Drug Administration (FDA) for CAPVAXIVE, previously known as V116, a 21-valent pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in the adult population.

RTTNews | 265 days ago

Swiss Market Ends Modestly Lower

Swiss Market Ends Modestly Lower

Save for a few minutes at the start, the Switzerland market languished in negative territory on Monday amid worries about the outlook for global economic growth after recent weak data from China and the U.S. rendered the mood cautious. Weak Swiss consumer confidence data, and the potential impact of tariffs from the Trump Administration weighed as well.

RTTNews | 4h 8min ago

European Markets Close Weak On Growth Worries

European Markets Close Weak On Growth Worries

European stocks closed on a weak note on Monday as rising economic uncertainty and tariff concerns rendered the mood bearish. Recent weak U.S. and Chinese economic data hurt as well.

RTTNews | 4h 24min ago

Swiss Franc Drops Against Majors

Swiss Franc Drops Against Majors

The Swiss franc fell against its major counterparts in the New York session on Monday.

RTTNews | 5h 11min ago

Dollar Tumbles As Trade War Ignites Growth Fears

Dollar Tumbles As Trade War Ignites Growth Fears

The U.S. dollar tumbled against major currencies during the week ended March 7 amidst an extended sell-off on Wall Street triggered by the escalation in the trade war and a weak labor market update.

RTTNews | 8h 58min ago

Bay Street Likely To Open On Weak Note

Bay Street Likely To Open On Weak Note

Canadian shares are likely to open on a negative note Monday morning amid fears of a U.S. recession, and rising concerns about China's growth outlook.

RTTNews | 9h 22min ago

Yen Rises Amid Risk Aversion

Yen Rises Amid Risk Aversion

The Japanese yen strengthened against other major currencies in the European session on Monday, as the investor sentiment fell on lingering tariff worries, the threat of a U.S. recession and signs of deepening deflationary pressures in China.

RTTNews | 10h 37min ago

Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the European session on Tuesday.

RTTNews | 11h 43min ago

Terms | Privacy | Site Map | Site Map Calendar

© 2025 Myfxbook Ltd. All Rights Reserved.

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.